INVO Fertility, Inc. (IVF) Form 8-K — Jun 22, 2026
INVO Fertility reported first quarter 2026 results showing revenue growth of 23% to $2.0 million, driven by organic initiatives and the acquisition of Family Beginnings. The company achieved significant balance sheet improvements, eliminating all Series C-2 Preferred Stock and warrant liabilities while increasing stockholders’ equity by 108% to $15.0 million. Despite the revenue gains, the company recorded a net loss of $5.5 million, which included a $3.8 million non-cash loss related to the reclassification of warrant liabilities to equity. This compares to a net loss of $1.5 million in the prior-year quarter from continuing operations.
Key figures
- Revenue
- 2015225
- Revenue Yoy
- 23%
- Cash Position
- 4900000
- Shares Outstanding
- 1786035
- Warrant Proceeds
- 7100000
- Total Liabilities
- 9600000
- Book Value Per Share
- 9.16
- Current Liabilities
- 6400000
- Stockholders Equity
- 15000000
- Consolidated Clinic Revenue
- 1982233
- Fully Diluted Shares Outstanding
- 4850000
Price after filing
Close on the filing date to close N calendar days later (from $1.39). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.